Successful treatment of erectile dysfunction and infertility by venesection in a patient with primary haemochromatosis

European Journal of Gastroenterology and Hepatology

Volumn 13, Issue 8, 2001, Pages 985-988

  Hamer, Okka W ^a   Gnad, Marcus ^a   Schölmerich, Jürgen ^a   Palitzsch, Klaus Dieter ^a  

^a University of Regensburg   (United States)

Author keywords

Haemochromatosis; Keywords; Reversibility; Secondary hypogonadism; Venesection

Indexed keywords

ANDROGEN; FERRITIN; FOLLITROPIN; LUTEINIZING HORMONE; TESTOSTERONE; TRANSFERRIN;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; ERECTILE DYSFUNCTION; FOLLITROPIN BLOOD LEVEL; HEMOCHROMATOSIS; HORMONE SUBSTITUTION; HUMAN; HYPOGONADOTROPIC HYPOGONADISM; IRON OVERLOAD; LABORATORY TEST; LUTEINIZING HORMONE BLOOD LEVEL; MALE; MALE INFERTILITY; PHLEBOTOMY; PRIORITY JOURNAL; TESTOSTERONE BLOOD LEVEL; TRANSFERRIN BLOOD LEVEL;

ADULT; ANDROGENS; FERRITINS; FOLLICLE STIMULATING HORMONE; HEMOCHROMATOSIS; HUMANS; HYPOGONADISM; IMPOTENCE; INFERTILITY, MALE; LUTEINIZING HORMONE; MALE; PHLEBOTOMY; TESTOSTERONE;

EID: 0034884112     PISSN: 0954691X     EISSN: 14735687     Source Type: Journal    
DOI: 10.1097/00042737-200108000-00021     Document Type: Article

References (25)

1. Beutler E. Genetic irony beyond haemochromatosis: clinical effects of HLA-H mutations. Lancet 1997; 349: 296-297.
2. Feder JN, Gnirke A, Thomas W, Tsuchihashi Z, Ruddy DA, Basava A. et al. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet 1996; 13: 399-408.
3. Bacon BR. Diagnosis and management of hemochromatosis. Gastroenterology 1997; 113: 995-999.
4. Wallace DF, Dooley JS, Walker AP. A novel mutation of HFE explains the classical phenotype of genetic hemochromatosis in a C282Y heterozygote. Gastroenterology 1999; 116: 1409-1412.
5. Powell LW, George DK, McDonnell SM, Kowdley KV. Diagnosis of hemochromatosis. Ann Intern Med 1998; 129: 925-931.
6. Eijkelkamp EJ, Yapp TR, Powell LW. HFE-associated hereditary hemochromatosis. Can J Gastroenterol 2000; 14: 121-125.
7. Pietrangelo A. Hemochromatosis 1998: is one gene enough? J Hepatol 1998; 29: 502-509.
8. Burke W, Thomson E, Khoury MJ, McDonnell SM, Press N, Adams PC. et al. Hereditary hemochromatosis: gene discovery and its implications for population-based screening. JAMA 1998; 280: 172-178.
9. Bacon BR, Powell LW, Adams PC, Kresina TF, Hoofnagle JH. Molecular medicine and hemochromatosis: at the crossroads. Gastroenterology 1999; 116: 193-207.
10. Adams PC, Kertesz AE, Valberg LS. Clinical presentation of hemochromatosis: a changing scene. Am J Med 1991; 90: 445-449.
11. McDonnell SM, Preston BL, Jewell SA, Barton JC, Edwards CQ, Adams PC. et al. A survey of 2,851 patients with hemochromatosis: symptoms and response to treatment. Am J Med 1999; 106: 619-624.
12. Bothwell TH, MacPhail AP. Hereditary hemochromatosis: etiologic, pathologic, and clinical aspects. Semin Hematol 1998; 35: 55-71.
13. Bergeron C, Kovacs K. Pituitary siderosis. A histologic, immunocytologic, and ultrastructural study. Am J Pathol 1978; 93: 295-309.
14. Williams TC, Frohman LA. Hypothalamic dysfunction associated with hemochromatosis. Ann Intern Med 1985; 103: 550-551.
15. Kelly TM, Edwards CQ, Meikle AW, Kushner JP. Hypogonadism in hemochromatosis: reversal with iron depletion. Ann Intern Med 1984; 101: 629-632.
16. McNeil LW, McKee LC Jr, Lorber D, Rabin D. The endocrine manifestations of hemochromatosis. Am J Med Sci 1983; 285: 7-13.
17. Bomford A, Williams R. Long-term results of venesection therapy in idiopathic haemochromatosis. Q J Med 1976; 45: 611-623.
18. Niederau C, Stremmel W, Strohmeyer GW. Clinical spectrum and management of haemochromatosis. Baillieres Clin Haematol 1994; 7: 881-901.
19. Lufkin EG, Baldus WP, Bergstralh EJ, Kao PC. Influence of phlebotomy treatment on abnormal hypothalamic-pituitary function in genetic hemochromatosis. Mayo Clin Proc 1987; 62: 473-479.
20. Stal P, Johansson I, Ingelman-Sundberg M, Hagen K, Hultcrantz R. Hepatotoxicity induced by iron overload and alcohol. Studies on the role of chelatable iron, cytochrome P450 2E1 and lipid peroxidation. J Hepatol 1996; 25: 538-546.
21. Jacob AK, Hotchkiss RS, DeMeester SL, Hiramatsu M, Karl IE, Swanson PE. et al. Endothelial cell apoptosis is accelerated by inorganic iron and heat via an oxygen radical dependent mechanism. Surgery 1997; 122: 243-253.
22. Cundy T, Butler J, Bomford A, Williams R. Reversibility of hypogonadotrophic hypogonadism associated with genetic haemochromatosis. Clin Endocrinol (Oxf) 1993; 38: 617-620.
23. Gama R, Smith MJ, Wright J, Marks V. Hypopituitarism in primary haemochromatosis; recovery after iron depletion. Postgrad Med J 1995; 71: 297-298.
24. Siemons LJ, Mahler CH. Hypogonadotropic hypogonadism in hemochromatosis: recovery of reproductive function after iron depletion. J Clin Endocrinol Metab 1987; 65: 585-587.
25. Kaymakoglu S, Okten A, Cakaloglu Y, Boztas G, Besisik F, Tascioglu C. et al. Hypogonadism is not related to the etiology of liver cirrhosis. J Gastroenterol 1995; 30: 745-750.